Squarepoint Ops LLC Raises Stake in Aspen Aerogels, Inc. (NYSE:ASPN)

Squarepoint Ops LLC lifted its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 41.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 402,446 shares of the construction company's stock after purchasing an additional 118,208 shares during the quarter. Squarepoint Ops LLC owned 0.49% of Aspen Aerogels worth $4,781,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Sandia Investment Management LP acquired a new position in shares of Aspen Aerogels in the 4th quarter worth approximately $89,000. AlphaQuest LLC increased its holdings in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock worth $135,000 after buying an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Aspen Aerogels in the fourth quarter worth about $164,000. Connors Investor Services Inc. bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $168,000. Finally, Journey Strategic Wealth LLC bought a new position in shares of Aspen Aerogels in the fourth quarter valued at approximately $178,000. 97.64% of the stock is owned by institutional investors.

Aspen Aerogels Trading Down 2.4%

Shares of NYSE:ASPN traded down $0.15 on Friday, hitting $5.82. 353,918 shares of the company's stock were exchanged, compared to its average volume of 1,998,514. Aspen Aerogels, Inc. has a 12 month low of $4.16 and a 12 month high of $33.15. The stock has a market capitalization of $477.44 million, a price-to-earnings ratio of 36.35 and a beta of 2.72. The business's 50 day simple moving average is $5.74 and its two-hundred day simple moving average is $9.43. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.93 and a quick ratio of 2.48.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. The company had revenue of $78.72 million for the quarter, compared to analyst estimates of $82.75 million. During the same quarter in the previous year, the firm earned ($0.02) earnings per share. The firm's quarterly revenue was down 16.7% compared to the same quarter last year. Analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling at Aspen Aerogels

In other Aspen Aerogels news, CEO Donald R. Young acquired 20,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was acquired at an average cost of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the transaction, the chief executive officer now directly owns 550,856 shares of the company's stock, valued at $2,947,079.60. This represents a 3.77% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 3.40% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have commented on ASPN shares. Craig Hallum decreased their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a "buy" rating on the stock in a research note on Friday, February 14th. Barclays restated an "equal weight" rating and set a $7.00 target price (down previously from $13.00) on shares of Aspen Aerogels in a report on Thursday. B. Riley lowered their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. TD Cowen upgraded shares of Aspen Aerogels to a "strong-buy" rating in a research note on Tuesday, March 11th. Finally, Wall Street Zen raised shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Aspen Aerogels has an average rating of "Moderate Buy" and a consensus target price of $18.44.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.